Surmodics Inc.

NASDAQ: SRDX · Real-Time Price · USD
38.31
0.67 (1.78%)
At close: Aug 15, 2025, 3:06 PM

Surmodics Income Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Revenue
29.57M 28.09M 29.92M 33.23M 30.34M 31.96M 30.55M 27.97M 52.48M 27.2M 24.93M 25.99M 24.85M 26.11M 23M 23.97M 23.87M 34.99M 22.3M
Cost of Revenue
8.58M 7.83M 7.42M 8.67M 9.32M 7.98M 17.47M 16.73M 18.15M 18.66M 18.01M 17.86M 18.12M 18.82M 16.16M 14.89M 17.35M 17.05M 14.63M
Gross Profit
20.99M 20.25M 22.5M 24.55M 21.02M 23.98M 13.09M 11.23M 34.33M 8.54M 6.92M 8.13M 6.74M 7.29M 6.84M 9.08M 6.52M 17.95M 7.67M
Operating Income
-5.24M -4.01M -2.48M -613K -5.37M 659K -322K -2.45M 21.41M -5.3M -7.23M -6.61M -7.14M -4.9M -3.44M -489K -2.38M 9.48M 93K
Interest Income
265K 253K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-5.93M -4.68M -2.94M -1.14M -5.81M 166K -724K -2.79M 20.65M -7.37M -8.01M -6.79M -7.18M -5M -3.52M -562K -2.51M 9.53M -106K
Net Income
-5.32M -5.21M -3.65M -3.45M -7.55M 247K -786K 6.69M 7.35M -7.73M -7.84M -14.73M -5.65M -4.08M -2.81M -289K -3.29M 8.09M -274K
Selling & General & Admin
17.75M 15.04M 15.17M 14.58M 16.63M 13.09M 12.54M 12.81M 12.87M 12.97M 13.24M 13.78M 12.85M 11.11M 9.19M 7.87M 7.88M 7.91M 7.02M
Research & Development
3.15M 3.19M 2.74M 2.69M 9.77M 10.23M 8.66M 9.7M 2.66M 2.42M 1.93M 2.08M 2.14M 2.3M 2.56M 2.86M 2.99M 3.16M 2.86M
Other Expenses
5.33M 6.04M 7.06M 7.9M n/a n/a -7.79M -8.82M 835K -1.55M -1.02M -1.12M -1.12M -1.23M 14.69M -73K 560K 560K 12.32M
Operating Expenses
26.23M 24.27M 24.98M 25.17M 26.39M 23.32M 13.41M 13.69M 13.75M 13.84M 14.15M 14.74M 13.88M 12.18M 10.28M 8.98M 8.45M 8.47M 7.58M
Interest Expense
865K 855K 882K 884K 879K 881K 896K 895K 884K 884K 826K 188K 145K 129K 136K 132K 59K 59K 60K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a -3K n/a 3K n/a n/a n/a n/a n/a 842K n/a n/a n/a
Cost & Expenses
34.81M 32.09M 32.4M 33.84M 35.71M 31.3M 30.87M 30.42M 31.91M 32.5M 32.16M 32.6M 31.99M 31M 26.44M 23.87M 25.8M 25.51M 22.2M
Income Tax Expense
-611K 527K 707K 2.31M 1.74M -81K 62K -9.48M 13.3M 368K -165K 7.94M -1.53M -919K -706K -273K 776K 1.44M 168K
Shares Outstanding (Basic)
14.28M 14.28M 14.23M 14.19M 14.17M 14.15M 14.1M 14.06M 14.05M 14.03M 13.98M 13.91M 13.78M 13.92M 13.88M 13.84M 13.7M 13.75M 13.67M
Shares Outstanding (Diluted)
14.28M 14.28M 14.23M 14.19M 14.17M 14.18M 14.1M 14.15M 14.07M 14.03M 13.98M 13.94M 13.93M 13.92M 13.88M 13.85M 13.84M 13.98M 13.67M
EPS (Basic)
-0.37 -0.36 -0.26 -0.24 -0.53 0.02 -0.06 0.48 0.52 -0.55 -0.56 -1.06 -0.41 -0.29 -0.2 -0.02 -0.24 0.59 -0.02
EPS (Diluted)
-0.37 -0.36 -0.26 -0.24 -0.53 0.02 -0.06 0.47 0.52 -0.55 -0.56 -1.06 -0.41 -0.29 -0.2 -0.02 -0.24 0.58 -0.02
EBITDA
-5.24M -4.01M 21K 1M -2.81M 2.75M 2.69M 430K 23.85M -4.23M -4.9M -4.21M -4.67M -2.44M -915K 1.98M -608K 11.39M 1.81M
EBIT
-5.06M -5.54M -2.06M -1.14M -4.93M 659K 172K -1.89M 21.53M -6.48M -7.18M -6.6M -7.04M -4.87M -3.38M -430K -2.45M 9.48M 93K
Depreciation & Amortization
2.1M 1.53M 2.08M 2.14M 2.13M 2.1M 2.52M 2.32M 2.31M 2.25M 2.28M 2.4M 2.37M 2.44M 2.47M 2.41M 1.84M 1.91M 1.86M